FCPM III Services B.V.

In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), FCPM III Services B.V. reported 8 stock positions worth $592.4 million. Its top holding was Newamsterdam Pharma (NAMS) at 46.0% of the portfolio, followed by Dyne Therapeutics (DYN, 21.7%) and Engene (ENGN, 10.8%). Compared with Q3 2024, it opened 1 new position, added to 2 and reduced 3. The biggest buy was a new position in Astria Therapeutics (ATXS) and the biggest sale Dyne Therapeutics (DYN, shares −8%).

Most Recent 13F
Q2 2026
Location
NAARDEN, P7
CIK
0002013410
Portfolio Value
$592.4M (Q4 2024)
SEC Filing
0000950123-25-002356 ↗ filed Feb 14, 2025

Holdings Value

0$200.0M$400.0M$600.0M$800.0M Q1 2024: $707.3M Q1 2024 Q2 2024: $678.1M Q2 2024 Q3 2024: $582.3M Q3 2024 Q4 2024: $592.4M $592.4M Q4 2024 Q1 2025: $413.7M Q1 2025 Q2 2025: $369.2M Q2 2025 Q3 2025: $500.4M Q3 2025 Q4 2025: $762.9M Q4 2025 Q1 2026: $722.2M Q1 2026 Q2 2026: $750.4M Q2 2026

Holdings 8 stocks · $592.4M
NAMS Newamsterdam Pharma Co. NV 45.98% 10,597,181 $272.3M Reduce -10.4%
DYN Dyne Therapeutics Inc. 21.73% 5,462,846 $128.7M Reduce -8.3%
ENGN Engene Holdings Inc. 10.81% 9,632,561 $64.1M Add +11.0%
BCYC Bicycle Therapeutics PLC-ADR 8.16% 3,452,330 $48.3M Add +47.5%
REPL Replimune Group Inc. 8.12% 3,970,668 $48.1M Reduce -18.4%
ATXS Astria Therapeutics Inc. 4.34% 2,872,537 $25.7M New
ACHL Achilles Therapeutics PL-ADR 0.46% 2,390,050 $2.7M No change
ENGENE HOLDINGS INC 0.41% 2,878,148 $2.4M No change

Portfolio Sells Q3 2024 → Q4 2024
DYN Dyne Therapeutics Inc. Reduce -8.3% 21.73% −15.00
REPL Replimune Group Inc. Reduce -18.4% 8.12% −1.04
NAMS Newamsterdam Pharma Co. NV Reduce -10.4% 45.98% +12.25

Portfolio Buys Q3 2024 → Q4 2024
ATXS Astria Therapeutics Inc. New 4.34% +4.34
ENGN Engene Holdings Inc. Add +11.0% 10.81% +0.98
BCYC Bicycle Therapeutics PLC-ADR Add +47.5% 8.16% −0.93

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 11$750.4MNAMS, MPLT, DYN, VOR, DMRA
Q1 2026 10$722.2MNAMS, DYN, VOR, ENGN, MPLT
Q4 2025 10$762.9MNAMS, DYN, ENGN, RAPT, MPLT
Q3 2025 9$500.4MNAMS, DYN, ENGN, ATXS, BCYC
Q2 2025 8$369.2MNAMS, DYN, REPL, ENGN, BCYC
Q1 2025 7$413.7MNAMS, DYN, ENGN, REPL, BCYC
Q4 2024 8$592.4MNAMS, DYN, ENGN, BCYC, REPL
Q3 2024 7$582.3MDYN, NAMS, ENGN, REPL, BCYC
Q2 2024 7$678.1MDYN, NAMS, ENGN, REPL, BCYC
Q1 2024 6$707.3MNAMS, DYN, ENGN, REPL, ENGENE HOLDINGS INC